Percutaneous vertebroplasty in osteoporosis, myeloma and Langerhans' cell histiocytosis.

Abstract

This review aims to assess the effectiveness of percutaneous vertebroplasty as a treatment for the severe refractory pain associated with vertebral fracture, in a group of patients with fractures secondary to either osteoporotic or neoplastic disease. A retrospective review of 20 patients treated with percutaneous vertebroplasty in Cork University Hospital up until March 2007 was carried out and a questionnaire was prepared and distributed. Prior to vertebroplasty, patients had been symptomatic with severe pain for a mean of 20.9 weeks. Of those thirteen whom replied to a postal questionnaire, 12 (92.3%) reported pain relief and this improvement occurred within 7 days in 9 (81.8%). This was associated with decreased analgesic requirements, as determined on chart review. Prior to the procedure only 5 (38.4%) were independently mobile and this figure rose to 10 (76.9%) afterwards, occurring within one week in the majority. Subjective outcomes were better in the group of patients with neoplasm-induced fractures.

• Authors: B Kevane, D Q Ryder, O Gilligan
• Journal: Irish medical journal (Ir Med J) 2009 Jul-Aug Vol. 102 Issue 7 Pg. 212-5 ISSN: 0332-3102 [Print] Ireland
• PMID: 19772001 (Publication Type: Journal Article)

Topics

• Aged
• Cohort Studies
• Female
• Fractures, Bone (etiology, therapy)
• Histiocytosis, Langerhans-Cell (complications, therapy)
• Humans
• Male
• Multiple Myeloma (complications, therapy)
• Osteoporosis (complications, therapy)
• Retrospective Studies
• Surveys and Questionnaires
• Treatment Outcome
• Vertebroplasty